Hospital Mater Dei S.A. (BVMF:MATD3)
Brazil · Delayed Price · Currency is BRL | Market Cap | 1.69B +8.6% |
| Revenue (ttm) | 2.32B +10.3% |
| Net Income | 141.80M +9.2% |
| EPS | 0.43 +15.6% |
| Shares Out | 330.93M |
| PE Ratio | 12.03 |
| Forward PE | 8.16 |
| Dividend | 0.15 (3.04%) |
| Ex-Dividend Date | Dec 9, 2025 |
| Volume | 56,600 |
| Open | 5.19 |
| Previous Close | 5.12 |
| Day's Range | 4.97 - 5.19 |
| 52-Week Range | 4.13 - 6.17 |
| Beta | 0.42 |
| Analysts | Buy |
| Price Target | 7.06 (+40.92%) |
| Earnings Date | Nov 6, 2026 |
About Hospital Mater Dei
Hospital Mater Dei S.A. operates hospitals in Brazil. It engages in data and artificial intelligence business. The company was incorporated in 1973 and is headquartered in Belo Horizonte, Brazil. Hospital Mater Dei S.A. is a subsidiary of JSS Empreendimentos e Administração LTDA. [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for MATD3 stock is "Buy." The 12-month stock price target is R$7.06, which is an increase of 40.92% from the latest price.
News
Hospital Mater Dei Earnings Call Transcript: Q2 2026
Record net revenue and EBITDA were achieved, driven by oncology and high-complexity care, with strong growth in newer and acquired units. Operational efficiency, disciplined capital allocation, and strategic partnerships underpin robust financial health and positive outlook.
Hospital Mater Dei Earnings release: Q2 2026
Hospital Mater Dei released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Hospital Mater Dei Document: Q2 2026
Hospital Mater Dei filed a regulatory document on August 13, 2026 disclosing important business information.
Hospital Mater Dei Slides: Q2 2026
Hospital Mater Dei has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Hospital Mater Dei Earnings Call Transcript: Q1 2026
Record Q1 2026 results with net revenue up 15% and EBITDA up 35% year-over-year, driven by higher average ticket, operational efficiency, and strong performance in oncology. Leverage improved, margins expanded, and disciplined capital allocation remains a priority.
Hospital Mater Dei Earnings release: Q1 2026
Hospital Mater Dei released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Hospital Mater Dei Slides: Q1 2026
Hospital Mater Dei has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Hospital Mater Dei Document: Q1 2026
Hospital Mater Dei filed a regulatory document on May 6, 2026 disclosing important business information.
Hospital Mater Dei Earnings release: Q4 2025
Hospital Mater Dei released its Q4 2025 earnings on March 22, 2026, summarizing the period's financial results.
Hospital Mater Dei Slides: Q4 2025
Hospital Mater Dei has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 22, 2026.
Hospital Mater Dei Earnings Call Transcript: Q3 2025
Record revenue and EBITDA were achieved through higher average ticket, operational efficiency, and growth in oncology and surgical complexity. Strong cash generation enabled deleveraging, while key units like Salvador and Nova Lima outperformed, supporting a positive outlook.
Hospital Mater Dei Earnings release: Q3 2025
Hospital Mater Dei released its Q3 2025 earnings on November 10, 2025, summarizing the period's financial results.
Hospital Mater Dei Slides: Q3 2025
Hospital Mater Dei has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 10, 2025.